CBS News
US · 2 hrs ago
✦ 72◉ Centre
FDA blocked melanoma drug as confusion reigned under Makary
72Credibility
0Ratings
0Comments
AI Analysis
Credibility 72/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ⚠ Misleading headline
The FDA blocked approval of a melanoma drug called RP1 during a period of internal confusion under FDA Commissioner Marty Makary, despite the treatment showing tumor shrinkage in a third of clinical trial patients.
FDA blocked melanoma drug as confusion reigned under Makary
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!